Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lactosan is a specialized biotechnology company focused on the development and production of probiotics and lactic acid bacteria. The company provides high-quality microbial solutions for animal nutrition, silage preservation, and the food industry, utilizing advanced fermentation and freeze-drying technologies. As a contract manufacturing organization (CMO), Lactosan offers expertise in strain-specific process development and large-scale stabilization of sensitive microorganisms. Since its acquisition by DSM (now DSM-Firmenich) as part of the Erber Group, the company has integrated its microbial expertise into a global portfolio of health and nutrition solutions. Its facilities in Austria are equipped for high-capacity production under stringent quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lactosan.